BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38244647)

  • 1. Development of immune cell delivery system using biodegradable injectable polymers for cancer immunotherapy.
    Yoshizaki Y; Horii K; Murase N; Kuzuya A; Ohya Y
    Int J Pharm; 2024 Mar; 652():123801. PubMed ID: 38244647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative Adhesion Prevention Using a Biodegradable Temperature-Responsive Injectable Polymer System and Concomitant Effects of the Chymase Inhibitor.
    Yoshizaki Y; Nagata T; Fujiwara S; Takai S; Jin D; Kuzuya A; Ohya Y
    ACS Appl Bio Mater; 2021 Apr; 4(4):3079-3088. PubMed ID: 35014396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular therapy for myocardial ischemia using a temperature-responsive biodegradable injectable polymer system with adipose-derived stem cells.
    Yoshizaki Y; Takai H; Mayumi N; Fujiwara S; Kuzuya A; Ohya Y
    Sci Technol Adv Mater; 2021; 22(1):627-642. PubMed ID: 34393660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodegradable Injectable Polymer Systems Exhibiting Temperature-Responsive Irreversible Sol-to-Gel Transition by Covalent Bond Formation.
    Yoshida Y; Kawahara K; Inamoto K; Mitsumune S; Ichikawa S; Kuzuya A; Ohya Y
    ACS Biomater Sci Eng; 2017 Jan; 3(1):56-67. PubMed ID: 33429686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temperature-responsive biodegradable injectable polymers with tissue adhesive properties.
    Fujiwara S; Yoshizaki Y; Kuzuya A; Ohya Y
    Acta Biomater; 2021 Nov; 135():318-330. PubMed ID: 34461346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extemporaneously preparative biodegradable injectable polymer systems exhibiting temperature-responsive irreversible gelation.
    Yoshida Y; Takata K; Takai H; Kawahara K; Kuzuya A; Ohya Y
    J Biomater Sci Polym Ed; 2017 Oct; 28(14):1427-1443. PubMed ID: 28494698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrogel/nanoadjuvant-mediated combined cell vaccines for cancer immunotherapy.
    Yang A; Bai Y; Dong X; Ma T; Zhu D; Mei L; Lv F
    Acta Biomater; 2021 Oct; 133():257-267. PubMed ID: 34407475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel composite drug delivery system for honokiol delivery: self-assembled poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) micelles in thermosensitive poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) hydrogel.
    Gong C; Shi S; Wang X; Wang Y; Fu S; Dong P; Chen L; Zhao X; Wei Y; Qian Z
    J Phys Chem B; 2009 Jul; 113(30):10183-8. PubMed ID: 19572675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodegradable injectable polymer systems exhibiting a longer and controllable duration time of the gel state.
    Yoshida Y; Takai H; Kawahara K; Mitsumune S; Takata K; Kuzuya A; Ohya Y
    Biomater Sci; 2017 Jun; 5(7):1304-1314. PubMed ID: 28594018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodegradability and biocompatibility of a pH- and thermo-sensitive hydrogel formed from a sulfonamide-modified poly(epsilon-caprolactone-co-lactide)-poly(ethylene glycol)-poly(epsilon-caprolactone-co-lactide) block copolymer.
    Shim WS; Kim JH; Park H; Kim K; Chan Kwon I; Lee DS
    Biomaterials; 2006 Oct; 27(30):5178-85. PubMed ID: 16797693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injectable and biodegradable temperature-responsive mixed polymer systems providing variable gel-forming pH regions.
    Yoshida Y; Kawahara K; Mitsumune S; Kuzuya A; Ohya Y
    J Biomater Sci Polym Ed; 2017; 28(10-12):1158-1171. PubMed ID: 28271953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjustable degradation and drug release of a thermosensitive hydrogel based on a pendant cyclic ether modified poly(ε-caprolactone) and poly(ethylene glycol)co-polymer.
    Wang W; Deng L; Liu S; Li X; Zhao X; Hu R; Zhang J; Han H; Dong A
    Acta Biomater; 2012 Nov; 8(11):3963-73. PubMed ID: 22835677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel strategy utilizing ultrasound for antigen delivery in dendritic cell-based cancer immunotherapy.
    Suzuki R; Oda Y; Utoguchi N; Namai E; Taira Y; Okada N; Kadowaki N; Kodama T; Tachibana K; Maruyama K
    J Control Release; 2009 Feb; 133(3):198-205. PubMed ID: 19000727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, Characteristics and Potential Application of Poly(β-Amino Ester Urethane)-Based Multiblock Co-Polymers as an Injectable, Biodegradable and pH/Temperature-Sensitive Hydrogel System.
    Huynh CT; Nguyen MK; Jeong IK; Kim SW; Lee DS
    J Biomater Sci Polym Ed; 2012; 23(8):1091-106. PubMed ID: 21619729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injectable polypeptide hydrogel-based co-delivery of vaccine and immune checkpoint inhibitors improves tumor immunotherapy.
    Song H; Yang P; Huang P; Zhang C; Kong D; Wang W
    Theranostics; 2019; 9(8):2299-2314. PubMed ID: 31149045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimized biodegradable polymeric reservoir-mediated local and sustained co-delivery of dendritic cells and oncolytic adenovirus co-expressing IL-12 and GM-CSF for cancer immunotherapy.
    Oh E; Oh JE; Hong J; Chung Y; Lee Y; Park KD; Kim S; Yun CO
    J Control Release; 2017 Aug; 259():115-127. PubMed ID: 28336378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodegradable in situ gel-forming controlled drug delivery system based on thermosensitive PCL-PEG-PCL hydrogel. Part 2: sol-gel-sol transition and drug delivery behavior.
    Gong C; Shi S; Wu L; Gou M; Yin Q; Guo Q; Dong P; Zhang F; Luo F; Zhao X; Wei Y; Qian Z
    Acta Biomater; 2009 Nov; 5(9):3358-70. PubMed ID: 19470411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of protein-loaded hydrogel particles in an aqueous two-phase system for coincident antigen and CpG oligonucleotide delivery to antigen-presenting cells.
    Jain S; Yap WT; Irvine DJ
    Biomacromolecules; 2005; 6(5):2590-600. PubMed ID: 16153096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injectable, self-gelling, biodegradable, and immunomodulatory DNA hydrogel for antigen delivery.
    Nishikawa M; Ogawa K; Umeki Y; Mohri K; Kawasaki Y; Watanabe H; Takahashi N; Kusuki E; Takahashi R; Takahashi Y; Takakura Y
    J Control Release; 2014 Apr; 180():25-32. PubMed ID: 24530618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation-regulated architecture of injectable smart hydrogels enhances humoral immune response and potentiates antitumor activity in human lung carcinoma.
    Duong HTT; Thambi T; Yin Y; Kim SH; Nguyen TL; Phan VHG; Kim J; Jeong JH; Lee DS
    Biomaterials; 2020 Feb; 230():119599. PubMed ID: 31718883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.